Merck charts course out of CDMO business with Lonza sale
Merck KGaA has moved to streamline its focus with the sale of its contract development and manufacturing organisation (CDMO) business to Lonza.
uniQure set for May FDA verdict on Huntington's gene therapy
The FDA has started its review of uniQure's gene therapy for neurodegenerative disorder Huntington's, but will require an advisory committee meeting.
Cure HHT wins inaugural Prix Galien Patient First Award
A patient-led initiative for hereditary haemorrhagic telangiectasia (HHT) has won the inaugural Prix Galien Patient First Award.
Ultragenyx gets first Euro nod for rare disease drug Dojolvi
Several years after its US approval, Ultragenyx's therapy for long-chain fatty acid oxidation disorders, Dojolvi, has been greenlit in the UK.
Fresenius doubles down on biosimilars with big WuXi alliance
Fresenius is already a player in the biosimilars market, and has ramped up its position via a deal with WuXi Bio that spans up to 37 candidates.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
LEAP HR: Life Sciences Europe
Europe’s Only Industry-Specific Meeting Advancing HR Excellence in Life Sciences
Rational Based Drug Design Summit Europe
Driving Safer, Faster & More Efficient Discovery Across Europe
Evolution Summit 2027 to Convene Senior Clinical Development...
Westlake Village, CA: Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives
ISMAI 2026: Florence to host international symposium on the ...
On 3 and 4 December, in the CTO Auditorium of Careggi University Hospital, clinicians, scientists and international experts will discuss clinical judgement, patient safety and professional acco
11th Liquid Biopsy for Precision Oncology Summit West Coast
Your industry-leading, flagship West Coast meeting uniting the global liquid biopsy community